Newly Diagnosed Meniere’s Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine

Abstract

Objective:

To describe the course of Meniere’s disease with noninvasive treatment during the first few years after initial diagnosis.

Methods:

A retrospective review of consecutive patients with newly diagnosed definite Meniere’s disease between 2013 and 2016 and a minimum follow-up of 1 year. Patients received a written plan for low sodium, water therapy, and treatment with a diuretic and/or betahistine. Subjects were screened and treated for vestibular migraine as needed. Vertigo control and hearing status at most recent follow-up were assessed.

Results:

Forty-four subjects had an average follow up of 24.3 months. Thirty-four percent had Meniere’s disease and vestibular migraine, and 84% had unilateral Meniere’s disease. Seventy-five percent had vertigo well controlled at most recent follow-up, with only noninvasive treatments. Age, gender, body mass index, presence of vestibular migraine, bilateral disease, and duration of follow-up did not predict noninvasive treatment failure. Worse hearing threshold at 250 Hz and lower pure tone average (PTA) at the time of diagnosis did predict failure. Fifty-two percent of ears had improved PTA at most recent visit, 20% had no change, and 28% were worse

Conclusions:

Encountering excellent vertigo control and stable hearing after a new diagnosis of Meniere’s disease is possible with noninvasive treatments. Worse hearing status at diagnosis predicted treatment failure.